ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,212Medicare Part D Prescriptions Filled, Including Refills

Rank: 269 out of 1121

$573K Total Retail Price of All Prescriptions

Rank: 316 out of 1121

568 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 7,645 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 489 252 S3 1 3
LISINOPRIL 362 293 2 4
AMLODIPINE BESYLATE 339 270 3 5
FUROSEMIDE 327 253 4 7
OMEPRAZOLE 322 254 5 6
SIMVASTATIN 309 241 6 1
LEVOTHYROXINE SODIUM 238 177 7 2
GABAPENTIN 207 137 8 13
CITALOPRAM HBR 187 150 9 18
WARFARIN SODIUM 180 139 10 11
ATENOLOL 169 127 11 16
POTASSIUM CHLORIDE 166 133 12 12
LOVASTATIN 154 95 13 26
RANITIDINE HCL 152 100 14 33
MELOXICAM 138 111 15 22
PREDNISONE 126 91 16 43
METOPROLOL TARTRATE 126 86 16 9
HYDROCHLOROTHIAZIDE 125 120 18 10
GLYBURIDE 119 88 R 19 51
METFORMIN HCL 118 59 20 8
CARISOPRODOL 118 40 R 20 72
ALENDRONATE SODIUM 111 108 22 37
AMITRIPTYLINE HCL 109 60 R 23 61
ENDOCET 107 61 S2 24 107
CLOPIDOGREL 107 66 24 27
AZITHROMYCIN 103 71 26 44
ATORVASTATIN CALCIUM 102 71 27 15
FLUOXETINE HCL 102 75 27 60
ISOSORBIDE MONONITRATE ER 100 95 29 62
NEXIUM 95 46 30 24
CARVEDILOL 87 80 31 20
ZOLPIDEM TARTRATE 84 42 32 19
LANTUS 84 40 32 52
PLAVIX 83 61 34 42
CELEBREX 82 60 35 104
FLUCONAZOLE 82 46 35 156
TRIAMTERENE-HCTZ 81 43 37 38
METHADONE HCL 75 11 S2 38 178
JANUVIA 75 62 38 81
PRAVASTATIN SODIUM 73 47 40 14
TRAZODONE HCL 72 54 41 40
METOPROLOL SUCCINATE 71 49 42 23
PROAIR HFA 71 21 42 48
DONEPEZIL HCL 71 58 42 35
DEXILANT 70 37 45 136
CLONIDINE HCL 69 56 46 39
TRAMADOL HCL 65 14 47 25
TERAZOSIN HCL 62 58 48 130
INSULIN SYRINGE 61 26 49 77
TAMSULOSIN HCL 60 24 50 32
ALLOPURINOL 55 39 51 30
DIGOXIN 55 47 51 59
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 29 53 108
SPIRIVA 54 26 53 49
LYRICA 53 19 55 76
CYMBALTA 52 25 56 50
DIOVAN 51 47 57 45
SPIRONOLACTONE 51 46 57 54
POLYETHYLENE GLYCOL 3350 51 44 57 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.